Question: What are the potential issues from the following stakeholder groups due to the FDA's approval of EXONDYS 51/VYONDYS 53? Patients? FDA? The manufacturer of EXONDYS 51/VYONDYS 53? Patient advocacy groups? Healthcare practitioners? Manufacturers of competitive products? How did FDA's decision to approve this pharmaceutical product impact each of these stakeholder groups? Need Assignment Help?